These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 34547999)

  • 1. Finding Appropriate Signal Peptides for Secretory Production of Recombinant Glucarpidase: An In SilicoMethod.
    Vakili O; Khatami SH; Maleksabet A; Movahedpour A; Fana SE; Sadegh R; Salmanzadeh AH; Razeghifam H; Nourdideh S; Tehrani SS; Taheri-Anganeh M
    Recent Pat Biotechnol; 2021; 15(4):302-315. PubMed ID: 34547999
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Suitable Signal Peptides for Secretory Production of Recombinant Granulocyte Colony Stimulating Factor in Escherichia coli.
    Tehrani SS; Goodarzi G; Naghizadeh M; Khatami SH; Movahedpour A; Abbasi A; Shabaninejad Z; Khalaf N; Taheri-Anganeh M; Savardashtaki A
    Recent Pat Biotechnol; 2020; 14(4):269-282. PubMed ID: 32838727
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In silico analysis of different signal peptides to discover a panel of appropriate signal peptides for secretory production of Interferon-beta 1b in Escherichia coli.
    Ghovvati S; Pezeshkian Z; Mirhoseini SZ
    Acta Biochim Pol; 2018 Oct; 65(4):521-534. PubMed ID: 30378597
    [TBL] [Abstract][Full Text] [Related]  

  • 4.
    Taheri-Anganeh M; Khatami SH; Jamali Z; Savardashtaki A; Ghasemi Y; Mostafavi-Pour Z
    Mol Biol Res Commun; 2019 Mar; 8(1):17-26. PubMed ID: 31528640
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In silico Analysis of Different Signal Peptides for Secretory Production of Arginine Deiminase in Escherichia coli.
    Zarei M; Nezafat N; Morowvat MH; Ektefaie M; Ghasemi Y
    Recent Pat Biotechnol; 2019; 13(3):217-227. PubMed ID: 30621572
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In silico analysis of different signal peptides for the secretory production of recombinant human keratinocyte growth factor in Escherichia coli.
    Dastjerdeh MS; Marashiyan M; Boroujeni MB; Golkar M; Shokrgozar MA; Rahimi H
    Comput Biol Chem; 2019 Jun; 80():225-233. PubMed ID: 30999249
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MTXPK.org: A Clinical Decision Support Tool Evaluating High-Dose Methotrexate Pharmacokinetics to Inform Post-Infusion Care and Use of Glucarpidase.
    Taylor ZL; Mizuno T; Punt NC; Baskaran B; Navarro Sainz A; Shuman W; Felicelli N; Vinks AA; Heldrup J; Ramsey LB
    Clin Pharmacol Ther; 2020 Sep; 108(3):635-643. PubMed ID: 32558929
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In Silico Investigation of Signal Peptide Sequences to Enhance Secretion of CD44 Nanobodies Expressed in Escherichia coli.
    Kavousipour S; Mohammadi S; Eftekhar E; Barazesh M; Morowvat MH
    Curr Pharm Biotechnol; 2021; 22(9):1192-1205. PubMed ID: 33045964
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Half-dose glucarpidase as efficient rescue for toxic methotrexate levels in patients with acute kidney injury.
    Heuschkel S; Kretschmann T; Teipel R; von Bonin S; Richter S; Quick S; Alakel N; Röllig C; Balaian E; Kroschinsky F; Knoth H; Bornhäuser M; von Bonin M
    Cancer Chemother Pharmacol; 2022 Jan; 89(1):41-48. PubMed ID: 34669022
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Analysis of different signal peptides for the secretory production of Ama r 2 in gram-positive systems (Lactococcus lactis).
    Vasiee A; Norouzi N; Yazdi FT; Mortazavi SA; Sankian M; Mahmoudi M; Shahidi F
    Microb Pathog; 2020 Jan; 138():103819. PubMed ID: 31669829
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Glucarpidase following high-dose methotrexate: update on development.
    Patterson DM; Lee SM
    Expert Opin Biol Ther; 2010 Jan; 10(1):105-11. PubMed ID: 19925307
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Routine use of low-dose glucarpidase following high-dose methotrexate in adult patients with CNS lymphoma: an open-label, multi-center phase I study.
    Schaff LR; Lobbous M; Carlow D; Schofield R; Gavrilovic IT; Miller AM; Stone JB; Piotrowski AF; Sener U; Skakodub A; Acosta EP; Ryan KJ; Mellinghoff IK; DeAngelis LM; Nabors LB; Grommes C
    BMC Cancer; 2022 Jan; 22(1):60. PubMed ID: 35027038
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Glucarpidase treatment for methotrexate intoxication: a case report and review of the literature.
    Boelens AD; Mathôt RAA; Vlaar APJ; Bouman CSC
    Neth J Med; 2018 Jan; 76(1):36-39. PubMed ID: 29380731
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Functional overexpression and purification of a codon optimized synthetic glucarpidase (carboxypeptidase G2) in Escherichia coli.
    Goda SK; Rashidi FA; Fakharo AA; Al-Obaidli A
    Protein J; 2009 Dec; 28(9-10):435-42. PubMed ID: 19911261
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Glucarpidase, leucovorin, and thymidine for high-dose methotrexate-induced renal dysfunction: clinical and pharmacologic factors affecting outcome.
    Widemann BC; Balis FM; Kim A; Boron M; Jayaprakash N; Shalabi A; O'Brien M; Eby M; Cole DE; Murphy RF; Fox E; Ivy P; Adamson PC
    J Clin Oncol; 2010 Sep; 28(25):3979-86. PubMed ID: 20679598
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Analyzing Signal Peptides for Secretory Production of Recombinant Diagnostic Antigen B8/1 from
    Khatami SH; Taheri-Anganeh M; Arianfar F; Savardashtaki A; Sarkari B; Ghasemi Y; Mostafavi-Pour Z
    Mol Biol Res Commun; 2020 Apr; 9(1):1-10. PubMed ID: 32582787
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Successful Treatment of Delayed Methotrexate Clearance Using Glucarpidase Dosed on Ideal Body Weight in Obese Patients.
    Krüger C; Engel N; Reinert J; Alsdorf W; Fiedler W; Dierlamm J; Bokemeyer C; Langebrake C
    Pharmacotherapy; 2020 May; 40(5):479-483. PubMed ID: 32239519
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A second administration of glucarpidase in a different cycle of high-dose methotrexate: Is it safe and effective in adults?
    Domingo-González A; Osorio S; Landete E; Monsalvo S; Díez-Martín JL
    J Oncol Pharm Pract; 2021 Apr; 27(3):734-738. PubMed ID: 32731844
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Production of "biobetter" glucarpidase variants to improve drug detoxification and antibody directed enzyme prodrug therapy for cancer treatment.
    AlQahtani AD; Al-Mansoori L; Bashraheel SS; Rashidi FB; Al-Yafei A; Elsinga P; Domling A; Goda SK
    Eur J Pharm Sci; 2019 Jan; 127():79-91. PubMed ID: 30343151
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Glucarpidase for the treatment of life-threatening methotrexate overdose.
    Tuffaha HW; Al Omar S
    Drugs Today (Barc); 2012 Nov; 48(11):705-11. PubMed ID: 23170306
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.